Trials / Completed
CompletedNCT00455884
A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency
International Cooperative Metabolic Study (iNCMS) of NutropinAq® [Somatropin (rDNA Origin) Injection] Replacement Therapy in Adults With Growth Hormone Deficiency
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 546 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, open-label, observational, post marketing surveillance program to collect information on the use of NutropinAq® in adults suffering from Growth Hormone Deficiency in Germany, Italy, and United Kingdom
Conditions
Timeline
- Start date
- 2006-06-01
- Completion
- 2011-12-01
- First posted
- 2007-04-04
- Last updated
- 2019-01-14
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00455884. Inclusion in this directory is not an endorsement.